Progress Toward an HIV Vaccine
>> YOUR LINK HERE: ___ http://youtube.com/watch?v=n3S83S6Pdn8
Learn about the development of HIV vaccine candidates and the launch of the NIAID-supported HVTN 702 clinical trial in South Africa, the first new HIV vaccine efficacy study in seven years. UPDATE: On Feb. 3, 2020, NIAID announced that it had stopped administering vaccines in HVTN 702 because an independent data and safety monitoring board found during an interim review that the regimen did not prevent HIV. No participant safety concerns were identified. Read more: https://bit.ly/2RQyIya
#############################


